Skip to main content

Table 1 Vaccination recommendations for older adults in Europe and the US

From: Vaccines for the elderly: current use and future challenges

  Influenzaa S. pneumoniaeb Herpes zosterd Tetanus Diphtheriai Pertussisj
Austria all adults > 50; PCV + PPVc > 50 every 5 yearse every 5 yearse every 5 yearse
Belgium > 65 > 65; PCV + PPVc   every 10 years every 10 years onceh
Bulgaria > 65 every 10 years every 10 years
Croatia > 65   once at 60
Cyprus > 65 > 65; PPV   every 10 years every 10 years
Czech Rep. all adults > 65; PCV + PPVc > 50 every 10 yearsf once at 65
Denmark > 65 > 65; PCV or PPV  
Estonia > 65   every 10 years every 10 years
Finland > 65 > 65; PCV or PPV   every 10 years every 10 years
France > 65 65-75 every 10 yearsg every 10 yearsg onceh
Germany > 60 > 60; PPV   every 10 years every 10 years onceh
Greece > 60 > 65; PCV > 60 every 10 years every 10 years onceh
Hungary > 60 > 50; PPV  
Iceland > 60 > 60; PPV  
Ireland > 65 > 65; PPV  
Italy > 65 > 65; PCV + PPVc > 65 every 10 years every 10 years every 10 years
Latvia > 65   every 10 years every 10 years
Liechtenstein > 65   every 10 yearsg every 10 yearsg every 10 yearsg
Lithuania > 65   every 5-10 years every 5-10 years
Luxembourg > 65 > 60; PCV + PPVc   every 10 years every 10 years every 10 years
Malta all adults > 65; PCV  
Netherlands > 60  
Norway > 65 > 65; PPV  
Poland all adults > 50; PCV   onceh onceh
Portugal > 65   every 10 yearsg every 10 yearsg
Romania > 65  
Slovakia > 60 > 60; PCV   every 15 years every 15 years
Slovenia all adults > 65;PCV or PPV   every 10 years every 10 years onceh
Spain > 65 > 65; PPV   once at 65 once at 65
Sweden > 65; PPV   every 20 years every 20 years
UK > 65 > 65; PPV > 70
USA all adults > 65; PCV + PPVc > 60 every 10 years every 10 years onceh
  1. Shown are recommendations for the general population for all countries listed by the European Centre for Disease Prevention and Control. Specific recommendations for risk groups (co-morbidities, health care personnel etc.) are available in most countries
  2. aannual vaccination, inactivated trivalent vaccine
  3. brecommendation for persons without prior vaccination against pneumococcal disease; no booster shots recommended for general population; recommendations may differ for persons with underlying medical conditions
  4. cone dose of PCV13 (pneumococcal conjugate vaccine) followed by 1 dose of PPV23 (pneumococcal polysaccharide vaccine)
  5. done dose, contraindicated in immunosuppressed patients (live vaccine)
  6. efor persons over 65 years; every 10 years for younger adults
  7. ffor persons over 65 years; every 10-15 years for younger adults
  8. gfor persons over 65 years; every 20 years for younger adults
  9. honce during adulthood
  10. ivaccine containing reduced diphtheria dose (d)
  11. jvaccine containing acellular pertussis antigens